.png)
Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication
But nearly four in 10 (38%) say they took the drugs solely to lose weight
Low fluid intake is the most modifiable risk factor
International journal of chronic obstructive pulmonary disease
PMCID: PMC11397063
Patel lost 22 pounds himself
US$ 26.45
US$ 27.80
US$ 24.38
US$ 24.80
US$ 20.85
